COβ curing of concrete and aggregate production permanently mineralises COβ in building products while improving strength by up to 30%. India's construction sector β consuming 380 MT of cement and billions of cubic metres of concrete annually β provides unlimited domestic demand.
COβ reacts with calcium silicate hydrates to form calcite β permanently stored, strength improved.
Concrete curing with COβ β also called mineral carbonation or COβ curing β is a process where freshly cast concrete products are exposed to a concentrated COβ atmosphere during the curing period. The COβ reacts with calcium silicate hydrate (CSH) phases in the cement paste to form stable calcite (CaCOβ) and amorphous silica (SiOβ). This carbonation reaction is the same reaction that causes ordinary concrete to slowly absorb COβ from the atmosphere over decades β COβ curing simply accelerates and concentrates the process using captured COβ in a controlled chamber.
The carbonation reaction permanently incorporates the COβ into the concrete matrix as a stable mineral solid β the COβ does not re-emit during the concrete product's service life (typically 50β100 years) or during demolition and recycling. COβ uptake per tonne of concrete ranges from 15β50 kg COβ/tonne depending on cement content, COβ concentration, curing time, and temperature. In addition to COβ storage, COβ curing improves concrete compressive strength by 10β30% β meaning either stronger concrete at the same cement content, or equivalent strength with reduced cement content (and therefore reduced production emissions).
Beyond COβ curing of fresh concrete, two related pathways offer additional COβ utilisation: COβ-mineralised aggregate production, where reactive minerals (steel slag, fly ash, concrete demolition waste) are reacted with COβ to produce dense, stable aggregate for concrete and road base; and COβ injection into fresh concrete mix (Carbicrete technology), where COβ is injected into the concrete batching process rather than in a curing chamber β enabling in-situ carbonation without dedicated curing infrastructure.
COβ uptake per tonne of concrete products in COβ curing β permanent mineralisation
Compressive strength improvement achievable with COβ curing vs. steam curing
India's annual cement production β creating massive COβ utilisation capacity in construction
Typical concrete service life β COβ stored permanently for the structure's entire lifecycle
Each application has different COβ uptake volumes, capital requirements, and market demand profiles.
Precast products β pipes, blocks, pavers, panels, railway sleepers β are manufactured in controlled environments ideal for COβ curing chambers. Highest COβ uptake per tonne. Several Indian precast manufacturers in Gujarat, Maharashtra, and AP are immediate deployment candidates.
COβ injected into the concrete mixer truck or batching plant β no dedicated curing chamber required. CarbonCure Technologies (Canada) system. Most scalable deployment pathway for India's 5,000+ ready-mix plants. Lower COβ uptake per batch but massive volume potential.
Steel slag, fly ash, and demolition concrete waste reacted with COβ to produce dense, stable aggregate. India produces 20 MT/year of steel slag β most landfilled. COβ-mineralised slag aggregate replaces quarried stone, simultaneously solving a waste problem and creating a COβ utilisation pathway.
AAC β lightweight aerated concrete blocks widely used in Indian housing β is produced in autoclaves that can be retrofitted for COβ injection. Large AAC manufacturers in Rajasthan, UP, and Maharashtra are prime candidates for COβ utilisation offtake agreements.
Roads, bridges, dams, and railway infrastructure β India's βΉ111 trillion National Infrastructure Pipeline β represent the largest potential demand for COβ-cured concrete. NCM is developing a policy brief for MoRTH and the National Highways Authority to include COβ-cured concrete specifications in infrastructure procurement standards.
India is currently the world's second-largest construction market by volume and is projected to become the largest by 2030. The National Infrastructure Pipeline (NIP) β a βΉ111 trillion (approximately USD 1.4 trillion) programme covering roads, railways, urban infrastructure, housing, and energy β will consume vast quantities of concrete, precast products, and aggregate between now and 2030. The COβ utilisation potential embedded in this construction programme is extraordinary: if 10% of India's concrete production incorporated COβ curing, the total COβ utilised would exceed 30 MT/year β more than the total capture volume of most national CCUS programmes.
The economics of COβ building materials in India are favourable compared to most other markets. The primary cost of COβ curing is the COβ itself β at USD 30β50/tonne (the cost of capture and compression from an industrial source), the COβ cost per tonne of concrete product is approximately USD 1.5β2.50. This cost is more than offset by the strength improvement (equivalent to using 10β15% less cement, saving USD 3β5 per tonne of concrete product) and by the carbon credit revenue from the permanently stored COβ (at India Carbon Market prices of USD 10β20/tonne COβ β this is a further USD 0.15β1.00 per tonne of concrete). COβ curing is therefore potentially cost-negative β it reduces concrete production cost while storing COβ.
NCM is developing a consortium model for COβ utilisation in India's construction sector β aggregating COβ demand from multiple precast and ready-mix concrete plants in an industrial cluster to create sufficient volume for a shared COβ supply pipeline from a nearby capture source. This model β with the Gujarat cement cluster as the first target β reduces the infrastructure cost per tonne of COβ utilised and creates a supply agreement structure that carbon project developers and DFI lenders can finance.
NCM's building materials advisory is structured around the supply-demand matching challenge β identifying the COβ source (capture plant), the COβ transport pathway (pipeline or tanker), the utilisation technology (CarbonCure in-situ injection, purpose-built curing chambers, or mineralised aggregate reactors), and the concrete product offtaker (precast manufacturer, ready-mix company, AAC producer). Each link in this chain requires separate commercial agreements, technical integration, and carbon accounting documentation.
Technology selection depends critically on the scale and flexibility requirements of each deployment. CarbonCure's in-situ injection technology β which injects COβ directly into the mixing truck at the batching plant β is the most scalable and lowest-capital option for India's fragmented ready-mix sector, where plant sizes typically range from 10,000β100,000 mΒ³/year. Purpose-built COβ curing chambers are better suited to large precast manufacturers (railway sleeper producers, pipe manufacturers, large panel producers) where capital investment is justified by throughput volume and where the 30% strength improvement creates the largest cost saving per tonne of product.
NCM also leads the policy engagement required to create public sector demand for COβ-cured concrete β because India's construction sector is dominated by public procurement through NHAI, MoRTH, Indian Railways, and state PWDs. Including COβ-cured concrete in these agencies' material specifications and procurement requirements creates the market certainty that private sector concrete producers need to invest in COβ curing infrastructure. NCM is developing the technical standards and procurement specification language for this policy intervention.
Whether you are a government body seeking policy advice, an industrial company facing CBAM exposure, or an investor seeking CCUS project opportunities β our team is ready to engage.